β-Amyloid Prions and the Pathobiology of Alzheimer’s Disease
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Alzheimer's disease (AD) is the most common neurodegenerative disease in humans and will pose a considerable challenge to healthcare systems in the coming years.Aggregation of the b-amyloid (Ab) peptide within the brain is thought to be an initiating event in AD pathogenesis.Many recent studies in transgenic mice have provided evidence that Ab aggregates become self-propagating during disease, leading to a cascade of protein aggregation in the brain, which may underlie the progressive nature of AD.The ability to self-propagate and the existence of distinct "strains" reveals that Ab aggregates exhibit many properties indistinguishable from those of prions composed of PrP Sc proteins.Here, we review the evidence that Ab can become a prion during disease and discuss how Ab prions may be important for understanding the pathobiology of AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051 · cited 2×
“2012); and (5) mutations in the genes encoding the presenilin proteins increase the relative abundance of pro-amyloidogenic Aβ isoforms and cause early-onset AD (Sherrington et al. 1995).”
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498 · cited 2×
“In contrast, mutations in the gene encoding tau result in the production of NFTs in the brain (Hutton et al. 1998; Spillantini et al. 1998), but not amyloid plaques.”
Phases of Aβ-deposition in the human brain and its relevance for the development of AD
Thal, D. R., Rüb, U., Orantes, M., & Braak, H. (2002) · Neurology · doi:10.1212/wnl.58.12.1791 · Cited by 3,490 · cited 3×
“Induced Aβ prions also appear to “spread” away from the original site of inoculation (Eisele et al. 2009; Ye et al. 2015b), providing a potential molecular explanation for the progression of Aβ pathology observed in AD patients (Thal et al. 2002).”
Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
Alzheimer disease in the United States (2010–2050) estimated using the 2010 census
Hebert, L. E., Weuve, J., Scherr, P. A., & Evans, D. A. (2013) · Neurology · doi:10.1212/wnl.0b013e31828726f5 · Cited by 2,642
Bard, F., Cannon, C., Barbour, R., Burke, R.-L., Games, D., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., et al. (2000) · Nature Medicine · doi:10.1038/78682 · Cited by 2,012 · cited 1×
“Indeed, Tg(AD) mice have been used to demonstrate that reducing levels of Aβ aggregates in the brain, either by vaccination or passive immunotherapy, can rescue cognitive deficits (Schenk et al. 1999; Bard et al. 2000; Janus et al.”
The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes
Benilova, I., Karran, E., & De Strooper, B. (2012) · Nature Neuroscience · doi:10.1038/nn.3028 · Cited by 1,962 · cited 2×
“Cleavage of C99 by γsecretase is heterogeneous in nature and results in the generation of Aβ peptides varying in length from 37 to 43 amino acids (Benilova et al. 2012).”
Citron, M., Oltersdorf, T., Haass, C., McConlogue, L., Hung, A. Y., Seubert, P., Vigo-Pelfrey, C., Lieberburg, I., & Selkoe, D. J. (1992) · Nature · doi:10.1038/360672a0 · Cited by 1,757 · cited 4×
“…gene encoding APP cause early-onset forms of AD and increase the production of Aβ or enhance its aggregation potential (Chartier-Harlin et al. 1991; Citron et al. 1992); (2) duplication of the APP coding locus results in early-onset AD (Rovelet-Lecrux et al. 2006); (3) in Down’s syndrome…”
InfluentialA mutation in APP protects against Alzheimer’s disease and age-related cognitive decline
Jonsson, T., Atwal, J. K., Steinberg, S., Snaedal, J., Jonsson, P. V., Bjornsson, S., Stefansson, H., Sulem, P., Gudbjartsson, D., Maloney, J., et al. (2012) · Nature · doi:10.1038/nature11283 · Cited by 1,738 · cited 2×
“…pathological changes in the brain (Wisniewski et al. 1985); (4) mutations in the APP gene that decrease Aβ production are protective against AD (Jonsson et al. 2012); and (5) mutations in the genes encoding the presenilin proteins increase the relative abundance of pro-amyloidogenic Aβ…”
Self-Propagating, Molecular-Level Polymorphism in Alzheimer's ß-Amyloid Fibrils
Petkova, A. T., Leapman, R. D., Guo, Z., Yau, W.-M., Mattson, M. P., & Tycko, R. (2005) · Science · doi:10.1126/science.1105850 · Cited by 1,687
Cited by
Genetics of β-Amyloid Precursor Protein in Alzheimer's Disease
TCW, J., & Goate, A. M. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a024539 · Cited by 242
Morris, G. P., Clark, I. A., & Vissel, B. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1918-8 · Cited by 212
Calcium Dyshomeostasis in Alzheimer’s Disease Pathogenesis
Cascella, R., & Cecchi, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094914 · Cited by 185
“According to this hypothesis, the starting event in AD is the aggregation and subsequent deposition of the Aβ peptide in the brain [20,21], resulting in the hyperphosphorylation of tau into NFTs and, ultimately, the degeneration of neurons.”
BackgroundAlzheimer disease and the periodontal patient: New insights, connections, and therapies
Ryder, M. I., & Xenoudi, P. (2021) · Periodontology 2000 · doi:10.1111/prd.12389 · Cited by 55
The modulation of neuroinflammation by inducible nitric oxide synthase
Justo, A. F. O., & Suemoto, C. K. (2022) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-021-00663-x · Cited by 44
Wang, X., Li, H., Sheng, Y., He, B., Liu, Z., Li, W., Yu, S., Wang, J., Zhang, Y., Chen, J., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.116071 · Cited by 29
Hsueh, S. C. C., Aina, A., Roman, A. Y., Cashman, N. R., Peng, X., & Plotkin, S. S. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00567 · Cited by 8
Hsueh, S. C. C., Aina, A., Roman, A. Y., Cashman, N. R., Peng, X., & Plotkin, S. S. (2021) · doi:10.1101/2021.09.13.460126 · Cited by 8
Metadata
- Authors
- Watts, J. C., & Prusiner, S. B.
- Venue
- Cold Spring Harbor Perspectives in Medicine
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2017-02-13
- Volume
- 8
- Issue
- 5
- Pages
- a023507
- ISSN
- 2157-1422 (ISSN-L)
- OpenAlex
- W2588650504
- Cited by
- 82
- References
- 32
- Type
- posted content
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.